Sean Salmon
Fortuna: 5 M $ al 31/05/2026
Fortuna: 5 M $ al 31/05/2026
Sean Salmon is currently Director at Adagio Medical Holdings, Inc. since 2025.
Formerly, Mr. Salmon was EVP & President of the Diabetes Operating Unit at Medtronic Plc from 2004 to 2021.
Education includes an undergraduate degree from Boston University and an MBA from Kellogg School of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MEDTRONIC PLC 0,01 % | 16/12/2024 | 64.722 ( 0,01 % ) | 5 M $ | 31/05/2026 |
-.--% | 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|
| Empresas | Cargo | Fin |
|---|---|---|
| MEDTRONIC PLC | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medtronic Plc
Medtronic Plc Medical SpecialtiesHealth Technology Provides medical technology services | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.